Annual Report and Accounts

Media Centre Careers Investors Contact Us

Annual Report and Accounts

Notice of Annual General Meeting

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that its Report and Accounts for the 18 month period ended 31 December 2018, together with its Notice of Annual General Meeting (“AGM”) and a Form of Proxy, will be mailed out to shareholders today.

These documents are available on the Company’s website:
http://18.134.157.221/wp-content/uploads/2020/10/190513-Creo-Medical_AR2018.pdf

The AGM will be held at 10 a.m. on Thursday 6 June 2019 at the Company’s registered office, Creo House, Unit 2, Beaufort Park, Beaufort Park Way, Chepstow, Wales NP16 5UH.

Posted 13/05/2019

For press enquiries please contact media@creomedical.com. For all other enquiries please visit our Contact page.

Further news

Explore more news

07 May 2026

Acceleration in delivering targeted therapy for pancreatic lesions in USA

Read

05 May 2026

SpydrBlade Flex used in novel bariatric endoscopic technique by leading US innovator

Read

29 April 2026

First UK private hospital use Speedboat for colorectal cancer case

Read

16 January 2026

New partnership brings Creo’s CROMA-powered GI devices to Scandinavia

Read

04 August 2025

South Wales Patient Interview Liz Thomas

Read

11 June 2025

MicroBlate™ Flex Achieves First-Patient Milestone in New European Lung Tumour Clinical Study

Read

11 June 2025

Creo Medical Secures FDA Clearance for SpydrBlade™ Flex, Advancing U.S. Market Launch

Read

28 May 2025

US Reimbursement milestone for Speedboat procedure further driving the roll-out of Creo’s products

Read

04 April 2025

Shining a Light on Gastrointestinal Endoscopy Experts

Read

20 March 2025

UK & EU Commercial launch of SpydrBlade™ Flex

Read

Explore more news

This information contained in this website is intended as general information to demonstrate Creo Medical’s product range for healthcare professionals only and not the general public. Not all products are cleared/approved for use in all territories, and accordingly the availability of products may vary depending on the territory and current regulatory requirements and/or medical practices in such territory. Please read our full disclaimer for further details.